Expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a appropriation provision: That the House of Representatives— supports the goals and ideals of World Sickle Cell Awareness Day; commits to ensuring equitable access to new sickle cell disease (referred to. It relies on appropriations. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a appropriation provision: That the House of Representatives— supports the goals and ideals of World Sickle Cell Awareness Day; commits to ensuring equitable access to new sickle cell disease (referred to...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a appropriation provision: That the House of Representatives— supports the goals and ideals of World Sickle Cell Awareness Day; commits to ensuring equitable access to new sickle cell disease (referred to.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a appropriation provision: That the House of Representatives— supports the goals and ideals of World Sickle Cell Awareness Day; commits to ensuring equitable access to new sickle cell disease (referred to.
Policy Domains
Sponsors
Legislative Progress
In CommitteeMr. Davis of Illinois (for himself and Ms. Sewell) submitted …
Referred to the House Committee on Energy and Commerce.
Submitted in House
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology